OverviewSuggest Edit
Accuray is a radiation oncology company that develops, manufactures, sells, and supports precise tumor treatment solutions. It delivers advanced treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Its proprietary products, the CyberKnife, TomoTherapy, and Radixact systems are capable of treating all standard radiation therapy indications including breast, prostate, lung, and head and neck cancers. The company caters to the healthcare sector.
| Type | Public | |
| Founded | 1990 | |
| HQ | Sunnyvale, CA, US | Map |
| Website | accuray.com | |
| Employee Ratings | More | |
| Overall Culture | D- | More |
Recent NewsAll News
- New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities
- Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology Used to Treat His Cancer
- CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
- NICE Endorses Radiosurgery Treatments for Trigeminal Neuralgia, Supporting Accuray CyberKnife® System Indications for Use
Key People/Management at Accuray
Joshua Levine
Chief Executive Officer
Suzanne Winter
President
Mika Nishimura
Independent Director
Scott Chapman
Senior Vice President, Global Service
Jesse Chew
Senior Vice President, General Counsel and Corporate Secretary
Byron C. Scott
Independent Director
Accuray Office Locations
Accuray has offices in Sunnyvale, Madison, Chengdu, Hong Kong and in 2 other locations
Sunnyvale, CA, US (HQ)
1310 Chesapeake Terrace
Madison, WI, US
1240 Deming Way
Chengdu, CN
No. 8, Kexin Road, Hi-Tech Zone (West Area)
Hong Kong, HK
15 Canton Road
Tokyo, JP
2-2-1 Otemachi, Chiyoda-ku
Morges, CH
Route de la Longeraie 9
Accuray Financials and Metrics
Accuray Revenue
Accuray's revenue was reported to be $396.29 m in FY, 2021 which is a 3.5% increase from the previous period.
| USD | |
|---|---|
Revenue (Q1, 2022) | 107.4m |
Gross profit (Q1, 2022) | 39.5m |
Gross profit margin (Q1, 2022), % | 36.8% |
Net income (Q1, 2022) | (1.0m) |
EBIT (Q1, 2022) | 2.4m |
Market capitalization (13-May-2022) | 210.0m |
Closing stock price (13-May-2022) | 2.3 |
Cash (30-Sept-2021) | 104.7m |
EV | 327.3m |
Accuray's current market capitalization is $210 m.
Annual
Annual
Annual
| USD | FY, 2019 |
|---|---|
EV/EBIT | 726.8 x |
EV/CFO | -14.3 x |
Revenue/Employee | 442.2k |
Debt/Equity | 3.2 x |
Debt/Assets | 0.4 x |
Financial Leverage | 8.8 x |
P/E Ratio | (20.4) |
Accuray Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Morphormics, Inc. | July 17, 2012 | $5.7 m |
| TomoTherapy Incorporated | March 07, 2011 | $277 m |
| Accuray Accelerator Technology (Chengdu) Company Limited | ||
| Accuray Asia Ltd. | ||
| Accuray Belgium BV | ||
| Accuray Brasil Comércio, Importação e Exportação de Equipamentos Médicos Ltda | ||
| Accuray Europe SAS | ||
| Accuray International SARL | ||
| Accuray Italy S.R.L | ||
| Accuray Japan K.K. |
Accuray Revenue Breakdown
Accuray revenue breakdown by business segment: 55.4% from Services and 44.6% from Products
Accuray revenue breakdown by geographic segment: 20.1% from China, 26.7% from Americas, 30.7% from Europe, Middle East, India and Africa, 6.7% from Asia Pacific and 15.8% from Japan
Accuray Cybersecurity Score
Accuray Environment, Social & Governance (ESG) Ratings
Accuray Online and Social Media Presence
3.52k Twitter followers
Accuray has 3.52k Twitter Followers. The number of followers has increased 0.9% month over month and increased 2.5% quarter over quarter
Accuray's Trends
Twitter Engagement Stats for @Accuray
6.8k
Tweets
1.1k
Following
3.5k
Followers
99
Tweets last 30 days
2.8
Avg. likes per Tweet
98%
Tweets with engagement
Accuray Company Culture
Overall Culture
D-
57/100
CEO Rating
D-
57/100
Compensation
C+
70/100
Accuray News and Updates
May 10, 2022
New Data Presented at ESTRO 2022 Reinforce Benefits of Accuray CyberKnife® and TomoTherapy® Platforms Across a Range of Indications and Complexities
More Than 70 Abstracts Build on the Clinical Evidence Supporting the Use of These Technologies SUNNYVALE, Calif., May 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that clinical studies continue to validate the versatility of the company's CyberKnife® and...
April 21, 2022
Owner of Arkansas Derby Winner Named Horse After the Life-Changing Accuray CyberKnife® Radiation Therapy Technology Used to Treat His Cancer
SUNNYVALE, Calif., April 21, 2022 /PRNewswire/ -- When Al Gold, the owner of the Arkansas Derby winner Cyberknife, received a diagnosis of prostate cancer, he was determined to find a potential cure for his disease while minimizing the impact of treatment on his daily life. Mr. Gold's...
March 08, 2022
CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
SUNNYVALE, Calif., March 8, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state using the Accuray CyberKnife® S7™ System. The entire CyberKnife procedure is typically...
February 28, 2022
NICE Endorses Radiosurgery Treatments for Trigeminal Neuralgia, Supporting Accuray CyberKnife® System Indications for Use
SUNNYVALE, Calif., Feb. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for Health and Care Excellence (NICE)* has endorsed the use of radiosurgery for trigeminal neuralgia (TN), strengthening the evidence for the company to market...
February 28, 2022
Radiation Therapy Equipment Market to grow at a CAGR of 9.19% by 2026 | Evolving Opportunities with Accuray Inc.& Bionix LLC | Technavio
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- 38% of the growth will originate from North America for the radiation therapy equipment market. The US is the key market for radiation therapy equipment market in North America. Market growth in this region will be faster than the growth of the...
February 10, 2022
Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
SUNNYVALE, Calif., Feb. 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a phase III, randomized controlled trial, TomoBreast, indicate post-surgery hypofractionated radiotherapy delivered with the TomoTherapy® System is superior to conventional...
Accuray Frequently Asked Questions
When was Accuray founded?
Accuray was founded in 1990.
Who are Accuray key executives?
Accuray's key executives are Joshua Levine, Suzanne Winter and Mika Nishimura.
How many employees does Accuray have?
Accuray has 995 employees.
What is Accuray revenue?
Latest Accuray annual revenue is $396.3 m.
What is Accuray revenue per employee?
Latest Accuray revenue per employee is $398.3 k.
Who are Accuray competitors?
Competitors of Accuray include Micro Systems Engineering, Distalmotion and Personalis.
Where is Accuray headquarters?
Accuray headquarters is located at 1310 Chesapeake Terrace, Sunnyvale.
Where are Accuray offices?
Accuray has offices in Sunnyvale, Madison, Chengdu, Hong Kong and in 2 other locations.
How many offices does Accuray have?
Accuray has 6 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies